NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nutromics

Nutromics

Private
MelbourneHealthcare & Life Scienceshttps://www.nutromics.com/

Last Round

Acceleration Round

Sep 2, 2025

Total Funding Raised

$18.13M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nutromics is a healthtech company that develops a wearable diagnostic platform featuring DNA-based sensors and microneedles for continuous, real-time monitoring of molecular biomarkers and therapeutic drugs.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

wearable biosensorlab-on-a-patchcontinuous monitoringDNA-based sensingremote patient monitoringRPMdigital healthbiomarker monitoringmedtechwearable diagnosticselectrochemical aptamer sensorsEAB sensorsmicroneedle technologyprecision medicineclinical diagnostic tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nutromics Comps

Public and private peers based on sector, stage, and business model.

Nutromics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nutromics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Acceleration RoundSep 2, 2025
GrantApr 27, 2024
VC RoundJun 8, 2023
SeedSep 8, 2022
GrantSep 29, 2021
Seed
Aug 27, 2021

Key People

Founding team and executive leadership

Peter Vranes

CEO Co-Founder

Founding Team

Rowan Wilkie

Chief Financial Officer

Executive Team

Nutromics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    Thomas M. Prescott appointed as chair of the board.

  • Sep 2, 2025

    $4.89M raised in an Acceleration Round.

Nutromics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nutromics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nutromics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMelbourne
Employee Range60
Year Founded2017
Last FundingSep 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.